- Lyra Therapeutics Inc at Cantor Fitzgerald Global Healthcare Conference TranscriptSep 26, 2023
- Lyra Therapeutics Inc at HC Wainwright Investment Conference - New York TranscriptSep 13, 2023
- Lyra Therapeutics Inc to discuss the topline results of the BEACON study Call TranscriptSep 12, 2023
- Lyra Therapeutics Inc at Jefferies Healthcare Conference TranscriptJun 07, 2023
- Lyra Therapeutics Inc at Bank of America Global Healthcare Conference TranscriptMay 10, 2023
- Lyra Therapeutics Inc at Jefferies London Healthcare Conference TranscriptNov 17, 2022
- Lyra Therapeutics Inc at Stifel Healthcare Conference TranscriptNov 15, 2022
- Lyra Therapeutics Inc at H C Wainwright Global Investment Conference (Virtual) TranscriptSep 14, 2022
- Lyra Therapeutics Inc Annual Shareholders Meeting TranscriptJun 16, 2022
- Lyra Therapeutics Inc at Jefferies Healthcare Conference TranscriptJun 09, 2022
- Lyra Therapeutics Inc at William Blair Growth Stock Conference TranscriptJun 06, 2022
- Lyra Therapeutics Inc at Bank of America Healthcare Conference TranscriptMay 12, 2022
- Q3 2021 Lyra Therapeutics Inc Earnings Call TranscriptNov 09, 2021$6.79 (-3.69%)Earnings
- Q2 2021 Lyra Therapeutics Inc Earnings Call TranscriptAug 09, 2021$6.69 (-4.02%)Earnings
- Lyra Therapeutics Inc at William Blair Biotech Focus Conference (Virtual) TranscriptJul 15, 2021
- Lyra Therapeutics Inc at Bank of America Global Research Healthcare Conference (Virtual) TranscriptMay 13, 2021
- Q4 2020 Lyra Therapeutics Inc Earnings Call TranscriptMar 09, 2021$14.6 (+2.17%)Earnings
- Lyra Therapeutics Inc in Maria Palasis & Strong Leadership in HealthTech TranscriptOct 08, 2020
- Q2 2020 Lyra Therapeutics Inc Earnings Call TranscriptAug 05, 2020$13.96 (+1.68%)Earnings
Lyra Therapeutics Inc at William Blair Growth Stock Conference Transcript
Thank you. I think we're going to get started. First of all, welcome, everyone. It's great to see everybody in person. I know we haven't had GSC in a number of years in person. So it's fantastic to see everyone and to see the great attendance this year. For those of you who don't know, my name is Tim Lugo. I'm the head of biotech and pharma research here at William Blair.
And it's my pleasure to welcome Lyra Therapeutics. Maria Palasis will be speaking. She is the CEO of Lyra Therapeutics. Also, Jason Cavalier will be attending the breakout and answer questions, if anyone is concerned about their financial guidance and/or funding of their expanding pipeline. And it's my pleasure to have Lyra here now.
I know it's not a great time in the market for small-cap pharma and biotech. However, Lyra is a great company to look at amongst kind of the turmoil we see in the markets. They have a great lead asset, LYR-201 (sic - see slide 2, "LYR-210"), which has fantastic Phase 2 data, has entered Phase 3. They have a great group of investors after the
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)